As of 2026-06-15, the Relative Valuation of Phathom Pharmaceuticals Inc (PHAT) is (28.70) USD. This relative valuation is based on P/E multiples. With the latest stock price at 10.37 USD, the upside of Phathom Pharmaceuticals Inc based on Relative Valuation is -376.7%.
The range of the Relative Valuation is (20.67) - (28.83) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 10.5x - 19.7x | 16.0x |
| Forward P/E multiples | 10.1x - 14.6x | 13.0x |
| Fair Price | (20.67) - (28.83) | (28.70) |
| Upside | -299.3% - -378.0% | -376.7% |
| Date | P/E |
| 2026-06-12 | -5.26 |
| 2026-06-11 | -5.21 |
| 2026-06-10 | -4.98 |
| 2026-06-09 | -4.98 |
| 2026-06-08 | -5.07 |
| 2026-06-05 | -5.14 |
| 2026-06-04 | -5.00 |
| 2026-06-03 | -5.12 |
| 2026-06-02 | -4.89 |
| 2026-06-01 | -4.69 |
| 2026-05-29 | -4.86 |
| 2026-05-28 | -5.23 |
| 2026-05-27 | -5.45 |
| 2026-05-26 | -5.63 |
| 2026-05-22 | -5.74 |
| 2026-05-21 | -5.87 |
| 2026-05-20 | -6.02 |
| 2026-05-19 | -5.78 |
| 2026-05-18 | -5.78 |
| 2026-05-15 | -6.02 |
| 2026-05-14 | -6.62 |
| 2026-05-13 | -6.37 |
| 2026-05-12 | -6.35 |
| 2026-05-11 | -6.20 |
| 2026-05-08 | -6.17 |
| 2026-05-07 | -6.20 |
| 2026-05-06 | -6.42 |
| 2026-05-05 | -6.39 |
| 2026-05-04 | -6.53 |
| 2026-05-01 | -6.09 |
| 2026-04-30 | -5.68 |
| 2026-04-29 | -5.97 |
| 2026-04-28 | -5.74 |
| 2026-04-27 | -5.88 |
| 2026-04-24 | -5.93 |
| 2026-04-23 | -6.17 |
| 2026-04-22 | -5.95 |
| 2026-04-21 | -6.53 |
| 2026-04-20 | -6.83 |
| 2026-04-17 | -6.69 |
| 2026-04-16 | -6.39 |
| 2026-04-15 | -6.49 |
| 2026-04-14 | -6.42 |
| 2026-04-13 | -6.42 |
| 2026-04-10 | -6.40 |
| 2026-04-09 | -6.41 |
| 2026-04-08 | -5.99 |
| 2026-04-07 | -5.86 |
| 2026-04-06 | -5.70 |
| 2026-04-02 | -5.75 |